Search results
Results From The WOW.Com Content Network
AstraZeneca stuck to its forecast for total revenue and core earnings per share to increase by low double-digit to low teens percentages in 2024. ... Stock market today: Stocks climb after ...
July 25, 2024 at 6:22 AM. Anglo-Swedish drugmaker AstraZeneca raised its full year sales and profit forecast on Thursday after beating analyst expectations for second-quarter revenue on strong ...
July 25, 2024 at 11:48 AM. Shares of AstraZeneca (NASDAQ: AZN) were sliding 3.2% lower as of 10:57 a.m. ET on Thursday. The decline came after the British drugmaker announced its second-quarter ...
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and AstraZeneca Plc wasn’t one of them. The 10 stocks that made ...
AstraZeneca's primary listing is on the London Stock Exchange and is a constituent of the FTSE 100 Index; it also has a secondary listing on the Nasdaq Stockholm. It is also listed on the American Nasdaq and is a Nasdaq-100 company. AstraZeneca has one of the highest market capitalisations of pharmaceutical companies worldwide. [11]
AstraZeneca’s top business, oncology, delivered a 15% jump (up 19% on const ... AstraZeneca forecasts total revenue and core EPS to increase by a mid-teens ... AZN stock is down 4.44% at $76.16 ...
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and AstraZeneca Plc wasn’t one of them. The 10 stocks that made ...
AstraZeneca (AZN) reported strong earnings Friday, including $22 billion, or 4% revenue growth, in the first half of the year, and kept its 2023 forecast stable.